Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials ; day:23 ; month:2 ; year:2022 ; pages:1-11
Cancer immunology immunotherapy ; (23.2.2022), 1-11
- Creator
-
Ormhøj, Maria
Abken, Hinrich
Hadrup, Sine R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-022-03163-y
- URN
-
urn:nbn:de:101:1-2022052522310881720179
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ormhøj, Maria
- Abken, Hinrich
- Hadrup, Sine R.
- SpringerLink (Online service)
Other Objects (12)
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Chimeric antigen receptor T‑cell therapy—a hematological success story
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Targeting Pim kinases in hematological cancers: molecular and clinical review
Therapeutic advances in the targeting of ROR1 in hematological cancers
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Chimeric antigen receptor T‑cell therapy—a hematological success story
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Targeting Pim kinases in hematological cancers: molecular and clinical review
Therapeutic advances in the targeting of ROR1 in hematological cancers
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Chimeric antigen receptor T‑cell therapy—a hematological success story
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Targeting Pim kinases in hematological cancers: molecular and clinical review
Therapeutic advances in the targeting of ROR1 in hematological cancers
Improvement of chimeric antigen receptor T cell therapy for patients with hematological malignancies
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers